Skip to main content
Genetic Testing

Cuba’s new relationship with U.S. could hold opportunities for investors

By September 27, 2015February 8th, 2019No Comments

The Memphis Business Journal reported on Harmonyx Diagnostic’s new genetic test for pain prescriptions: “One in three Americans report suffering from chronic pain. With the serious risks and side effects associated with most pain medications, the test can help ensure a prescription isn’t negatively affecting a patient. The test could also help decrease the rate of abuse and overdose of opioids.”

Read the entire story here: